|
Category:information only not used for fragrances or flavors
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Soluble in: |
| | water, 2.677e-007 mg/L @ 25 °C (est) |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-dog LD > 1000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
unreported-dog LD > 3000 mg/kg Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 37, Pg. 2518, 1995.
intravenous-dog LD50 > 40 mL/kg BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BLOOD: PIGMENTED OR NUCLEATED RED BLLOD CELLS Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
oral-mouse LD > 5 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
intravenous-mouse LD50 > 40 mL/kg SKIN AND APPENDAGES (SKIN): HAIR: OTHER Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
intraperitoneal-mouse LDLo 5000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
intravenous-rabbit LD > 100 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 461, 1971.
oral-rat LD > 5000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
intravenous-rat LD50 > 40 mL/kg SKIN AND APPENDAGES (SKIN): HAIR: OTHER Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 2003, 1991.
intraperitoneal-rat LDLo 5000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
|
| Dermal Toxicity: |
subcutaneous-mouse LDLo 5000 mg/kg Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
subcutaneous-rabbit LDLo 100 mg/kg SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 461, 1971.
subcutaneous-rat LD > 5000 mg/kg SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 445, 1971.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | information only not used for fragrances or flavors |
| Recommendation for menatetrenone usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for menatetrenone flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | 2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 5282367 |
| Pubchem (cas): | 863-61-6 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | kephton | | | menaquinone-4 | | 2- | methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-naphthoquinone | | 2- | methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione | | | vitamin K2 |
Articles:
|